COVID-19 virus’s weekly COVID-19 news round-up

pharmafile | April 28, 2021 | News story | Research and Development COVID-19, covid 19 news, covid-19 news, news roundup, pharma, pharma news 

The past week has seen plenty of COVID-19 news continue to roll in: The European Commission has sued AstraZeneca over its vaccine supplies, Bharat Biotech’s jab has shown 100% efficacy in a new trial, and an Antivirals Taskforce has been set up in the UK to find the most promising antiviral medicines.

1. European Commission sues AstraZeneca over COVID-19 jab supplies – Published 27/04/2021

The European Commission (EC) announced yesterday that it was suing AstraZeneca for failing to respect its contract to supply COVID-19 vaccines to EU countries.

2. Jubilant’s oral remdesivir formulation shows positive results in human trial – Published 22/04/21

Jubilant Pharma has announced the successful completion of studies in human volunteers for their oral formulation of remdesivir – an FDA-approved treatment for COVID-19.

3. Bharat Biotech jab shows 100% efficacy against severe COVID-19 – Published 22/04/21

Indian biopharma company, Bharat Biotech, has reported interim analysis results from the Phase III trial of its COVID-19 vaccine, Covaxin, showed 100% efficacy against severe SARS-CoV-2 infection, with an overall efficacy of 78%.

4. J&J COVID-19 vaccine to resume Europe rollout – Published – 21/04/21

The Johnson & Johnson COVID-19 vaccine will continue its rollout in Europe, following a review from the EMA.

5. UK Government launches COVID-19 Antivirals Taskforce – Published 21/04/21

A new Antivirals Taskforce has been launched by the government to identify treatments for UK patients who have been exposed to COVID-19, searching for the most promising novel antiviral medicines that can be taken at home, and supporting their development through clinical trials.

Related Content

FDA approves first oral antiviral to treat adult patients with COVID-19

The US Food and Drug Administration (FDA) has announced that it has approved the oral …


Moderna and Pfizer COVID-19 vaccine protection declines over time

Data presented by Pfizer and Moderna ahead of the FDA’s vaccine advisory committee meeting on …

Sanofi complete acquisition of mRNA company Translate Bio

French pharma giants Sanofi continues its run of acquisitions in 2021 by completing the deal …

Latest content